发明名称 |
L-FMAU ZUR BEHANDLUNG VON HEPATITIS-DELTA-VIRUS-INFIZIERUNG |
摘要 |
A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog that suppresses the expression of the hepatitis B surface or preS1 antigen in the host 100-fold or more relative to pretreatment values in vivo; or to not more than 1 microgram per milliliter in vivo. In a preferred embodiment, the nucleoside is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof. |
申请公布号 |
DE60123042(D1) |
申请公布日期 |
2006.10.26 |
申请号 |
DE2001623042 |
申请日期 |
2001.03.29 |
申请人 |
GEORGETOWN UNIVERSITY;CORNELL RESEARCH FOUNDATION INC.;UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. |
发明人 |
CASEY, L.;KORBA, E.;COTE, J.;GERIN, L.;TENNANT, C.;CHU, K. |
分类号 |
A61K31/7072;G01N33/50;A61K31/7088;A61K31/7105;A61K38/00;A61K38/21;A61K39/395;A61K45/00;A61K45/06;A61K48/00;A61P1/16;A61P31/14;A61P31/20;A61P43/00;C07H19/06;C07H19/10;C12N9/00;C12N15/09;C12N15/113;G01N33/15;G01N33/576 |
主分类号 |
A61K31/7072 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|